|

memory-like natural killer cells Clinical Trials

1 actively recruiting trial across 1 location

Also known as: ML NK cells

Pipeline

Phase 1/2: 1

Top Sponsors

  • Washington University School of Medicine1

Indications

  • Acute Myeloid Leukemia, Pediatric1
  • Aml1
  • Acute Myeloid Leukemia1
  • AML, Childhood1
  • Cancer1

St Louis, Missouri1 trial

Pilot Study of Memory-like Natural Killer (ML NK) Cells After TCRαβ T Cell Depleted Haploidentical Transplant in AML

Washington University School of Medicine

Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.